PHILADELPHIA / LONDON (IT BOLTWISE) – Ladder Bio Inc., formerly ThirdLaw Molecular, has repositioned itself to address diseases previously considered ‘undruggable’ with its innovative spiroligomer platform. With a recently completed $5.5 million seed financing and new leadership, the company plans to further develop its unique therapeutic approaches.
Today’s daily deals at Amazon! ˗ˋˏ$ˎˊ˗
Ladder Bio Inc., previously known as ThirdLaw Molecular, has repositioned itself to explore new therapeutic avenues with its spiroligomer technology. This platform is based on so-called ‘ladder-shaped’ molecules that combine both the precision of biologics and the stability of small molecules. The aim is to treat diseases that were previously considered difficult to access with conventional medicines.
The company’s rebrand follows a successful seed funding round that raised $5.5 million. This was led by Medical Excellence Capital, with additional support from Hatch BioFund. With Eric Heil as its new CEO and experienced industry leaders David Scheer and Brian Halak on the board, Ladder Bio is well positioned to further develop its technologies.
Ladder Bio’s spiroligomer technology aims to fill a chemical niche that combines the benefits of biologics and small molecules. These molecules are designed to combine the potency and precision of biologics with the stability and oral administration of small molecules. This could open up new therapeutic opportunities for diseases where existing technologies have failed.
The fresh investment will be used to scale the platform, validate leading programs, initiate early in vitro studies and expand the scientific and development team. The new executives bring decades of experience in biopharma company building, venture capital investments and operational strategy to help the company advance to the next phase of development.
Order an Amazon credit card without an annual fee with a credit limit of 2,000 euros!
Bestseller No. 1 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 2 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 3 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 4 ᵃ⤻ᶻ «KI Gadgets»
Bestseller No. 5 ᵃ⤻ᶻ “KI Gadgets”
Please send any additions and information to the editorial team by email to de-info[at]it-boltwise.de. Since we cannot rule out AI hallucinations, which rarely occur with AI-generated news and content, we ask you to contact us via email and inform us in the event of false statements or misinformation. Please don’t forget to include the article headline in the email: “Ladder Bio: New Approach to Combat ‘Undruggable’ Diseases”.